Sinsin Pharmaceutical Co. Ltd (002800) — Financial Flexibility Index
Sinsin Pharmaceutical Co. Ltd (002800) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of ₩5.57 Billion (operating CF ₩4.70 Billion minus capex ₩871.54 Million) represents 0% of total liabilities (₩65.10 Billion). Also explore Sinsin Pharmaceutical Co. Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sinsin Pharmaceutical Co. Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Check strategic asset allocation of Sinsin Pharmaceutical Co. Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sinsin Pharmaceutical Co. Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Sinsin Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see 002800 market cap.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | ₩7.46 Billion | ₩5.94 Billion | ₩63.61 Billion | ▼ -18.4% |
| 2023 | 0.14x | ₩8.96 Billion | ₩3.93 Billion | ₩62.32 Billion | ▲ +38.9% |
| 2022 | 0.10x | ₩6.37 Billion | ₩5.46 Billion | ₩61.52 Billion | ▲ +127.2% |
| 2021 | 0.05x | ₩2.71 Billion | ₩23.18 Million | ₩59.38 Billion | ▼ -79.6% |
| 2020 | 0.22x | ₩13.83 Billion | ₩1.87 Billion | ₩61.94 Billion | ▲ +1.7% |
| 2019 | 0.22x | ₩16.00 Billion | ₩-4.51 Billion | ₩72.87 Billion | ▼ -55.3% |
| 2018 | 0.49x | ₩26.21 Billion | ₩774.24 Million | ₩53.38 Billion | ▲ +61.3% |
| 2017 | 0.30x | ₩8.14 Billion | ₩4.57 Billion | ₩26.74 Billion | ▲ +2.4% |
| 2016 | 0.30x | ₩10.22 Billion | ₩2.79 Billion | ₩34.38 Billion | — |